BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations·PRINCETON, NJ·FY end 12/31·CIK 14272

CEO Pay Ratio

131:1

Christopher S. Boerner

CEO Total Comp

—

Christopher S. Boerner

Median Employee

—

Revenue

$48.2B

FY 2025

Net Income

$7.1B

FY 2025

Free Cash Flow

$12.8B

FY 2025

Net Margin

14.6%

Insider Net (180d)

-$1.9M

0 buys / 2 sales

CEO Pay Accountability

CEO comp as % of net income

—

Not enough data to compute.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$48.2B	$48.3B	$45.0B	$46.2B	$46.4B
Gross Profit	—	—	—	—	—	—
Operating Income	—	—	—	—	—	—
Net Income	$7.1B	-$8.9B	$8.0B	$6.3B	$7.0B
Operating CF	$14.2B	$15.2B	$13.9B	$13.1B	$16.2B
Capex	$1.3B	$1.2B	$1.2B	$1.1B	$973.0M
Free Cash Flow	$12.8B	$13.9B	$12.7B	$11.9B	$15.2B
Buybacks	$0	$0	$5.2B	$8.0B	$6.3B
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—
Net Margin	14.6%	-18.5%	17.8%	13.7%	15.1%
FCF Margin	26.7%	28.9%	28.1%	25.9%	32.8%
R&D / Revenue	20.6%	23.1%	20.7%	20.6%	24.5%
Effective Tax	24.4%	-6.6%	4.7%	17.7%	13.4%
Debt / Equity	4.75	5.94	2.59	2.38	2.34
Buybacks / FCF	0.0%	0.0%	40.7%	67.0%	41.3%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
<UNKNOWN>	—	—	—	—	—	—
Adam LenkowskyEVP, Chief Commercialization Officer	$1.1M	$1.8M	—	$6.2M	$9.6M	—
Christopher S. BoernerPh.D. Board Chair and Chief Executive Officer	$1.6M	$3.8M	—	$16.5M	$21.9M	—
David V. ElkinsEVP and Chief Financial Officer	$1.1M	$1.8M	—	$6.2M	$9.2M	—
Greg MeyersEVP, Chief Digital and Technology Officer	$1.1M	$1.7M	—	$4.4M	$7.2M	—